Research shows tumor debulking in advanced colorectal cancer does not enhance survival outcomes and may increase adverse ...

High preoperative HBsAg levels are associated with an increased risk for recurrence following curative resection among patients with HBV-related hepatocellular carcinoma.

Imaging suggests HCC, yet cirrhosis is uncertain—see why biopsy matters and how AFP, spread, and liver function shape treatment. For oncology clinicians, the Liver Imaging-Reporting and Data System ...

Add Yahoo as a preferred source to see more of our stories on Google. A Cell Metabolism study reports that EVT0185 reduced scarring in disease models and may offer a new path for treating MASH.

A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the risks climb toward cancer, heart attack, stroke, and even transplant. Now, ...

Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns. For ...

The University of Missouri and MU Health Care recently started a first round of in-person trials of a new cancer treatment. The School of Medicine, ABK Biomedical and the University of Missouri ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...

Prof. Terence Lee, Associate Head and Professor of the PolyU Department of Applied Biology and Chemical Technology, and his research team have developed a novel antibody targeting the ...

The medication is really taking care of business. A pair of new Canadian clinical trials show poop pills can reduce the toxic side effects of cancer medications and even support patient response to ...